Restivo James P 4

4 · Benefitfocus,Inc. · Filed Apr 3, 2020

Form 4

Period: 2020-04-01

Chief Technology Officer

Transactions

Exercise/Conversion
Common Stock
[F1]
2020-04-01−901→ 82,506 total
Sale
Common Stock
[F2]
2020-04-01$8.15/sh−6,894$56,186→ 75,612 total
Exercise/Conversion
Performance Restricted Stock Units
[F1]
2020-04-01−901→ 2,101 total
Exp: 2020-04-01→ Common Stock (901 underlying)
Disposition to Issuer
Performance Restricted Stock Units
[F3]
2020-04-01−2,101→ 0 total
Exp: 2020-04-01→ Common Stock (2,101 underlying)
Disposition to Issuer
Performance Restricted Stock Units
[F3]
2020-04-01−16,014→ 0 total
Exp: 2023-04-01→ Common Stock (16,014 underlying)

Footnotes (3)

[F1]Shares earned upon the vesting of a percentage of the performance restricted stock units ("PRSUs") granted to the Reporting Person on April 1, 2019. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of an annual revenue goal and an adjusted EBITDA goal, during the period of January 1, 2019 through December 31, 2019.
[F2]This sale was executed in multiple trades at prices ranging from $7.99 to $8.63. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction were effected.
[F3]Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

Signature

/s/ S. Halle Vakani, Attorney-in-Fact|2020-04-03

Documents

1 file